Cannabigerol Mitigates Haloperidol-Induced Vacuous Chewing Movements in Mice
Neurotoxicity Research · 2025
DOI: 10.1007/s12640-024-00724-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurotoxicity Research, 2025. Verfasst von R Ponciano und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. Hauptthemen laut MEDLINE: Cannabinoids, Haloperidol, Mastication. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Chronic use of typical antipsychotics can lead to varying motor effects depending on the timing of analysis. Acute treatment typically induces hypokinesia, resembling parkinsonism, while repeated use can result in tardive dyskinesia, a hyperkinetic syndrome marked by involuntary orofacial movements, such as vacuous chewing movements in mice. Tardive dyskinesia is particularly concerning due to its potential irreversibility and associated motor discomfort. One prevailing theory suggests that tardive dyskinesia arises from hypersensitivity of D2-type dopaminergic receptors caused by continuous blockade from typical antipsychotics like haloperidol. Additionally, increased inflammation, oxidative stress, and elevated FosB protein expression in the dorsolateral striatum are implicated in its pathophysiology. Current treatments for tardive dyskinesia often lack clear efficacy and may lead to significant side effects. Cannabigerol, a non-psychotomimetic cannabinoid with antioxidant and anti-inflammatory properties, has been investigated for its potential antidyskinetic effects. In this study, mice were treated with cannabigerol at doses of 3 and 10 mg/kg to evaluate its ability to prevent, ameliorate, or reverse haloperidol-induced vacuous chewing movements. Cannabigerol successfully reduced vacuous chewing movements without affecting normal motor activity, exacerbating haloperidol-induced hypokinesia, or inducing dyskinetic effects on its own. However, no significant reversal of the haloperidol-induced motor effects was observed under the current protocol. Furthermore, cannabigerol did not alter FosB expression or microglia morphology. These findings underscore the need for further research to explore cannabigerol's therapeutic potential and contribute to our understanding of its possible clinical applications in managing tardive dyskinesia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
- Department of Neurosciences and Behavioral Sciences, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
- Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.
- Department of Physiology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. eadelbel@usp.br.
- Department of Neurosciences and Behavioral Sciences, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. eadelbel@usp.br.
- Department of Basic and Oral Biology, School of Dentistry of Ribeirão Preto, University of São Paulo, Av. Do Café s/n, Ribeirão Preto, São Paulo, Ribeirão Preto, SP, 14049-900, Brazil. eadelbel@usp.br.
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Ponciano, R., Hallak, J. E. C., Crippa, J. A., Guimarães, F. S., & Bel, E. A. D. (2025). Cannabigerol Mitigates Haloperidol-Induced Vacuous Chewing Movements in Mice. Neurotoxicity Research. https://doi.org/10.1007/s12640-024-00724-0
Vancouver
Ponciano R, Hallak JEC, Crippa JA, Guimarães FS, Bel EAD. Cannabigerol Mitigates Haloperidol-Induced Vacuous Chewing Movements in Mice. Neurotoxicity Research. 2025. doi:10.1007/s12640-024-00724-0
BibTeX
@article{Ponciano2025,
author = {Ponciano, R and Hallak, J E C and Crippa, J A and Guimarães, F S and Bel, Elaine Ap Del},
title = {Cannabigerol Mitigates Haloperidol-Induced Vacuous Chewing Movements in Mice},
journal = {Neurotoxicity Research},
year = {2025},
doi = {10.1007/s12640-024-00724-0}
}
EUVIMED